More than 2,400 hospitals and over 2,000 outpatient providers worldwide participate in one or more of the ACC’s eight registries, forming a comprehensive network of cardiovascular care providers committed to ensuring evidence-based cardiovascular care, improving patient outcomes and lowering health care costs.
The ACC’s NCDR offers five hospital-based registries:
The ACTION Registry®
–GWTG™ is a risk-adjusted, outcomes-based quality improvement program that focuses exclusively on high-risk STEMI/NSTEMI patients. It helps hospitals apply ACC/AHA clinical guideline recommendations in their facilities and provides invaluable tools to measure care and achieve quality improvement goals.
The CathPCI Registry®
assesses the characteristics, treatments and outcomes of cardiac disease patients who receive diagnostic catheterization and/or percutaneous coronary intervention (PCI) procedures. This powerful tool captures the data that measure adherence to ACC/AHA clinical practice guideline recommendations, procedure performance standards and appropriate use criteria for coronary revascularization.
The ICD Registry
™ establishes a national standard for understanding treatment patterns, clinical outcomes, device safety and the overall quality of care provided to implantable cardioverter defibrillator (ICD) patients. As the CMS-mandated registry for hospitals that perform ICD implantation procedures, the ICD Registry plays an important role in determining the association between evidence-based treatment strategies and clinical outcomes. Eighty percent of participating hospitals value the registry beyond the CMS-mandate – capturing all ICD implantations regardless of payer or indication.
The IMPACT Registry®
assesses the prevalence, demographics, management and outcomes of pediatric and adult congenital heart disease (CHD) patients who undergo diagnostic catheterizations and catheter-based interventions. Its data support the development of evidence-based guidelines for CHD treatment that will improve outcomes for CHD patients of all ages.
The PVI Registry™
assesses the prevalence, demographics, management and outcomes of patients undergoing lower extremity peripheral arterial catheter-based interventions and includes carotid artery stenting (CAS) and carotid endarterectomy (CEA). The PVI Registry provides data collection and equips clinicians with decision-making data whether care is provided in a hospital cath lab, interventional radiology department, or an outpatient vascular center.
The ACC offers cardiology’s largest quality improvement registry for outpatient cardiovascular care
focuses on coronary artery disease, hypertension, heart failure, atrial fibrillation and diabetes in the outpatient setting. Its HIPAA-compliant data collection option works with most EHR systems and its unique online portal delivers on-demand reports for viewing overall clinical care, accessing QI best practices, and maximizing PQRS and eRx incentives.
Currently, the ACC is a partner in the following registries:
The STS/ACC TVT Registry™
monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures – emerging treatments for valve disease patients. Employing state-of-the-art heart valve technology, transcatheter heart valve procedures provide new treatment options for patients who are not eligible for conventional heart valve replacement or repair surgery. Learn more about the TVT Registry
The Diabetes Collaborative Registry™ is the first clinical ambulatory registry aimed at tracking and improving the quality of diabetes and cardiometabolic care across the primary and specialty care continuum. The combined data from primary care physicians, endocrinologists, cardiologists and other diabetes care providers allows for longitudinal study of diabetes making this a valuable resource that reveals new insights, drives decision-making and enables better treatment and improved outcomes. Learn more about the Diabetes Collaborative Registry